FDA.reportPublic FDA data

selinexor 50 MG Oral Tablet

RxCUI
2548738
RxNorm name
selinexor 50 MG Oral Tablet
Display name
selinexor 50 MG Oral Tablet
Full name
selinexor 50 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XPOVIOSELINEXORKaryopharm Therapeutics Inc.f6dd2682-75a6-4863-90a8-a3197f6f78a82026-05-12Warnings, Adverse reactionsExact identifier
rxcui: 2548738

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f6dd2682-75a6-4863-90a8-a3197f6f78a8selinexor 50 MG Oral Tablet [PSN] · selinexor 50 MG Oral Tablet [SCD]218These highlights do not include all the information needed to use XPOVIO safely and effectively. See full prescribing information for XPOVIO. XPOVIO ® (selinexor) tablets, for oral use Initial U.S. Approval: 201920260512